Loading…
Synthesis and biological evaluation of the novel purine and pyrimidine nucleoside analogues containing 2,3-epoxypropyl, 3-amino-2-hydroxypropyl or 2,3-epoxypropyl ether moieties
The novel purine and pyrimidine nucleoside analogues possessing a 2,3-epoxypropyl ( 2a– 2c and 8a– 8c), 2,3-epoxypropyl ether ( 3), or 3-amino-2-hydroxypropyl ( 4a– 6c and 9a– 9c) moiety bonded at either N-9 of the C-6 substituted purine ring or N-1 and N-3 of the pyrimidine ring, were prepared and...
Saved in:
Published in: | European journal of medicinal chemistry 1999-05, Vol.34 (5), p.405-413 |
---|---|
Main Authors: | , , , |
Format: | Article |
Language: | English |
Subjects: | |
Citations: | Items that this one cites Items that cite this one |
Online Access: | Get full text |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Summary: | The novel purine and pyrimidine nucleoside analogues possessing a 2,3-epoxypropyl (
2a–
2c and
8a–
8c), 2,3-epoxypropyl ether (
3), or 3-amino-2-hydroxypropyl (
4a–
6c and
9a–
9c) moiety bonded at either N-9 of the C-6 substituted purine ring or N-1 and N-3 of the pyrimidine ring, were prepared and evaluated on their antitumour and antiviral activities. Compounds
3,
6b,
8b and
8c showed marked inhibition of growth of human tumour cell lines (MiaPaCa2 and Raji), whilst the inhibitory effect of
6b was greater against Raji cells than to the MiaPaCa2 ones. No specific activity of compounds
2a–
3,
4a–
6c and
9a–
9c against HSV and VZV was detected. The compound
6b was slightly active against the replication of HIV 1 (III
B), while
2a-
2c and
8a-
8c were inactive. |
---|---|
ISSN: | 0223-5234 1768-3254 |
DOI: | 10.1016/S0223-5234(99)80090-7 |